R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA

P3746692

Specialty

Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes.

Titles and Roles

Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Professor, Department of Pharmacology and Chemical Biology
Emory University School of Medicine
Director, Phase I Clinical Trials Program
Winship Cancer Institute of Emory University
Medical Director, Clinical Trials Office
Winship Cancer Institute of Emory University
Oncology Pharmacist
Phase I Clinical Trials Unit
Research Program
Discovery and Developmental Therapeutics

Biography

R. Donald Harvey, PharmD, is Professor in the Department of Hematology and Medical Oncology with a joint appointment in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine. A board certified oncology pharmacist, Dr. Harvey serves as director of Winship Cancer Institute's Phase I Clinical Trials Unit. He also serves as Medical Director of Winship's Clinical Trials Office, where he works to ensure the quality and compliance of clinical research practices at all Winship locations. He is a Fellow of the American College of Clinical Pharmacy and a Fellow of the Hematology/Oncology Pharmacy Association.

Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes. An active principal and co-investigator on multiple trials, he also consults on experimental design of preclinical and clinical studies with a focus on optimizing correlative measures. Specific areas of research interest include agent tolerability and disposition in renal and hepatic impairment, effects of novel immunotherapeutics on hepatic metabolism, and use of therapeutic drug monitoring for anticancer agents.

Dr. Harvey is also active nationally and internationally in several cancer and pharmacology professional organizations. He is also a past president of the Hematology and Oncology Pharmacy Association, an international professional organization.

Education

Dr. Harvey obtained his BS Pharmacy and Doctor of Pharmacy degrees at the University of North Carolina at Chapel Hill (UNC).  He completed subsequent training at the University of Kentucky Medical Center and School of Pharmacy and specialized in Hematology/Oncology at UNC, where he was on staff and faculty for 8 years prior to coming to Grady Hospital in Atlanta where he served as a clinical specialist in hematology and oncology and director of the hematology and oncology residency program.

Research

Dr. Harvey's research interests include the clinical application of pharmacokinetic, pharmacodynamic, and pharmacogenomic data to patient care.

  • Below is a listing of current federal grants for the above principal investigator.

    GrantNumberTitle

Publications

Dr. Harvey is widely published in peer-reviewed journals. 

  • PublicationsPublication Date

Awards

Select awards and honors for Dr. Harvey include:

  • Award of Excellence, Hematology/Oncology Pharmacy Association (HOPA), 2018
  • James R. Eckman Award for Teaching Excellence, Emory School of Medicine Hematology and Medical Oncology Fellowship Program, 2014

Additional Websites

Cascade Link   TOP